These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34408744)
1. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study. Liu J; Shen Y; Wen Z; Xu Q; Wu Z; Feng H; Li Z; Dong X; Huang S; Guo J; Zhang L; Chen Y; Li W; Zhu W; Du H; Liu Y; Wang T; Chen L; Teboul JL; Annane D; Chen D Front Immunol; 2021; 12():673693. PubMed ID: 34408744 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199 [TBL] [Abstract][Full Text] [Related]
3. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients. Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H Front Immunol; 2021; 12():568789. PubMed ID: 34149679 [TBL] [Abstract][Full Text] [Related]
4. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study. Wu M; Ji JJ; Zhong L; Shao ZY; Xie QF; Liu ZY; Wang CL; Su L; Feng YW; Liu ZF; Yao YM Int Immunopharmacol; 2020 Nov; 88():106873. PubMed ID: 32795897 [TBL] [Abstract][Full Text] [Related]
5. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities. Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572 [TBL] [Abstract][Full Text] [Related]
6. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study. Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098 [TBL] [Abstract][Full Text] [Related]
8. Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy. Li X; Liu L; Yang Y; Yang X; Wang C; Li Y; Ge Y; Shi Y; Lv P; Zhou H; Luo P; Huang S Int Immunopharmacol; 2021 Jan; 90():107022. PubMed ID: 33160854 [TBL] [Abstract][Full Text] [Related]
9. Coronavirus Disease 2019 ICU Patients Have Higher-Than-Expected Acute Physiology and Chronic Health Evaluation-Adjusted Mortality and Length of Stay Than Viral Pneumonia ICU Patients. Higgins TL; Stark MM; Henson KN; Freeseman-Freeman L Crit Care Med; 2021 Jul; 49(7):e701-e706. PubMed ID: 33861555 [TBL] [Abstract][Full Text] [Related]
10. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study. Li Y; Li CS Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133 [TBL] [Abstract][Full Text] [Related]
13. Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study. Cui X; Yu X; Wu X; Huang L; Tian Y; Huang X; Zhang Z; Cheng Z; Guo Q; Zhang Y; Cai Y; Zhan Q Kidney Blood Press Res; 2020; 45(4):612-622. PubMed ID: 32712607 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil. Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806 [TBL] [Abstract][Full Text] [Related]
16. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R; JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924 [TBL] [Abstract][Full Text] [Related]
17. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial. Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies. McNicholas BA; Rezoagli E; Simpkin AJ; Khanna S; Suen JY; Yeung P; Brodie D; Li Bassi G; Pham T; Bellani G; Fraser JF; Laffey J; Crit Care; 2023 Jan; 27(1):3. PubMed ID: 36604753 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135 [TBL] [Abstract][Full Text] [Related]
20. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients. Liu D; Yu Z; Yin J; Chen Y; Zhang H; Xin F; Fu H; Wan B J Crit Care; 2017 Jun; 39():259-266. PubMed ID: 28069319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]